SNGX
Soligenix, Inc.NASDAQHealthcare$1.14+0.00%ClosedMarket Cap: $11.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.12
P/S
0.00
EV/EBITDA
-0.33
DCF Value
$1.27
FCF Yield
-89.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-248.0%
ROA
-123.1%
ROIC
-201.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-3.2M | $-3.1M | $0.32 | — |
| FY 2025 | $0.00 | NaN% | $-11.8M | $-11.6M | $-2.14 | — |
| Q3 2025 | $0.00 | NaN% | $-2.6M | $-2.5M | $-0.58 | — |
| Q2 2025 | $0.00 | NaN% | $-2.8M | $-2.7M | $-0.82 | — |
| Q1 2025 | $0.00 | NaN% | $-3.3M | $-3.2M | $-1.06 | — |
| Q4 2024 | $0.00 | NaN% | $-3.7M | $-3.0M | $-1.19 | — |
| FY 2024 | $0.00 | -Infinity% | $-9.4M | $-8.3M | $-4.98 | — |
| Q3 2024 | $0.00 | NaN% | $-1.9M | $-1.7M | $-0.78 | — |
| Q2 2024 | $0.00 | -Infinity% | $-1.7M | $-1.6M | $-1.31 | — |
| Q1 2024 | $117.0K | 0.0% | $-2.1M | $-1.9M | $-2.91 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.1M | $-1.8M | $-2.80 | — |
| FY 2023 | $0.00 | -Infinity% | $-7.7M | $-6.1M | $-12.66 | — |